Telehealth start up Coviu wins 2021 Australian Technologies Competition

Banner Image

27 October 2021

Pictured: Coviu CEO and co-founder Dr Silvia Pfeiffer 

Eleven of Australia's best emerging technology companies were crowned winners at last night's Australian Technologies Competition (ATC21) national awards ceremony, held virtually from Melbourne.

Hosted by media personality, TV presenter and author James O'Loghlin - stakeholders of the innovation ecosystem across government, private enterprise, the investment and scaleup community watched on as this year's winners were announced, including telehealth solution Coviu, manufacturing company FormFlow and cybersecurity's Haventec. 

NSW-based start up Coviu took home not only the Medtech & Pharma Award but also the title of Australian Technology Company of the Year.

Coviu, a spin out from CSIRO’s Data61, has developed a video telehealth solution powering simple, secure and feature-rich video consultations for healthcare professionals - integrating video with clinical tools.

MTPConnect's Senior Director BioMedTech Horizons Program Dr Gerard Gibbs presented the MedTech and Pharma Award to Dr Silvia Pfeiffer, Coviu's Chief Executive Officer and co-founder (with Nathan Oehlman).  

Congratulations to the other finalists in the category:

  • Victorian-based Lenexa Medical, developing personalised, pressure injury (PI) prevention and patient monitoring, focused on reducing the burden on healthcare systems
  • Queensland-based biotech Microbio delivering a paradigm shift in patient care through unique, specific, sensitive and rapid pathogen identification tests.

Patrick Mooney, Executive Chair of competition organiser Impact Tech Ventures says "We're delighted to celebrate this year's winners and also showcase Australia's emerging diversity in tech. We aim to find the best Australian scaleups, provide them with the best mentoring and growth support possible and connect them with relevant international partners. This year's winners provide timely solutions to many of the most significant challenges and opportunities that Australia faces."

In a six month program, entrants go through a three-stage judging process, receive free mentoring, submit a concise business plan and take part in a highly rated International Growth Masterclass. They also have access to deep dive programs on key growth topics and key markets. The final step is a pitch in front of an independent panel of Judges and a live audience. 

MTPConnect was pleased to sponsor the Medtech and Pharma Category Award for the sixth consecutive year, along with fellow Industry Growth Centres, AustCyber, FIAL, MetsIgnited and NERA with the support of the Department of Industry, Science, Energy and Resources (DISER). This is the Competition's eleventh year.